外周血炎性指标在新辅助化疗后的三阴性乳腺癌中的临床研究
Clinical Study of Peripheral Blood Inflammatory Indicators in Triple-Negative Breast Cancer after Neoadjuvant Chemotherapy
DOI: 10.12677/ACM.2023.13102268, PDF,   
作者: 于怡淼, 张碧媛*：青岛大学附属医院肿瘤放疗科，山东 青岛
关键词: 新辅助化疗；三阴性乳腺癌；中性粒细胞；NLR；Neoadjuvant Chemotherapy； Triple-Negative Breast Cancer； Neutrophils； NLR
摘要: 目的：观察不同外周血炎性指标对三阴性乳腺癌患者新辅助化疗疗效的预测作用以及和临床病理因素的关系。方法：选取青岛大学附属医院2022年1月~2023年1月收治的70例三阴性乳腺癌患者，提取新辅助化疗前外周血中性粒细胞计数、淋巴细胞计数、中性粒细胞/淋巴细胞比例(NLR)、血小板/淋巴细胞比例(PLR)、淋巴细胞/单核细胞比例(LMR)，讨论其与临床病理因素及病理完全缓解(pCR)的关系。结果：NLR与年龄和RCB分级密切相关，NLR水平越低，年龄越大，RCB分级越低。PLR水平与MP分级有关，PLR水平越低，MP分级越低。低水平中性粒细胞、低水平NLR与pCR有关。结论：中性粒细胞、NLR可作为预测三阴性乳腺癌新辅助化疗后是否达到pCR的指标。
Abstract: Objective: To observe the predictive effect of different peripheral blood inflammatory indexes on neoadjuvant chemotherapy in patients with triple-negative breast cancer and the relationship be-tween them and clinicopathological factors. Methods: 70 patients with triple-negative breast cancer admitted to the Affiliated Hospital of Qingdao University from January 2022 to January 2023 were selected. Peripheral blood neutrophil count, lymphocyte count, neutrophil/lymphocyte (NLR), platelet/lymphocyte (PLR) and lymphocyte/monocyte (LMR) were extracted before neoadjuvant chemotherapy. Discuss its relationship with clinicopathological factors and pathological complete response (pCR). Results: NLR was closely related to age and RCB grading. The lower the level of NLR, the older the age, the lower the RCB grading. PLR level is related to MP rating, the lower the PLR level, the lower the MP rating. Low levels of neutrophils and low levels of NLR were associated with pCR. Conclusion: Neutrophils and NLR can be used to predict whether pCR is achieved after neoad-juvant chemotherapy for triple-negative breast cancer.
文章引用：于怡淼, 张碧媛. 外周血炎性指标在新辅助化疗后的三阴性乳腺癌中的临床研究[J]. 临床医学进展, 2023, 13(10): 16223-16230. https://doi.org/10.12677/ACM.2023.13102268

参考文献

[1] Fredriksson, I., Liljegren, G., Arnesson, L.G., Emdin, S.O., Palm-Sjövall, M., Fornander, T., Frisell, J. and Holmberg, L. (2001) Time Trends in the Results of Breast Conservation in 4694 Women. European Journal of Cancer, 37, 1537-1544. [Google Scholar] [CrossRef] 
[2] Garrido-Castro, A.C., Lin, N.U. and Polyak, K. (2019) Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treat-ment. Cancer Discovery, 9, 176-198. [Google Scholar] [CrossRef] 
[3] Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immun-ity, Inflammation, and Cancer. Cell, 140, 883-899. [Google Scholar] [CrossRef] [PubMed]
[4] Xiong, S., Dong, L. and Cheng, L. (2021) Neutrophils in Cancer Carcinogenesis and Metastasis. Journal of Hematology & Oncology, 14, Article No. 173. [Google Scholar] [CrossRef] [PubMed]
[5] Shen, M., Hu, P., Donskov, F., Wang, G., Liu, Q. and Du, J. (2014) Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis. PLOS ONE, 9, e98259. [Google Scholar] [CrossRef] [PubMed]
[6] Nelson, M.A., Ngamcherdtrakul, W., Luoh, S.W. and Yantasee, W. (2021) Prognostic and Therapeutic Role of Tumor-Infiltrating Lymphocyte Subtypes in Breast Cancer. Cancer and Metastasis Reviews, 40, 519-536. [Google Scholar] [CrossRef] [PubMed]
[7] Guthrie, G.J., Charles, K.A., Roxburgh, C.S., Horgan, P.G., McMillan, D.C. and Clarke, S.J. (2013) The Systemic Inflammation-Based Neutrophil-Lymphocyte Ratio: Experience in Patients with Cancer. Critical Reviews in Oncology/Hematology, 88, 218-230. [Google Scholar] [CrossRef] [PubMed]
[8] Singh, S., Singh, J., Ganguly, R., Chandra, S., Samadi, F.M. and Suhail, S. (2021) Diagnostic Efficacy of Neutrophil to Lymphocyte Ratio (NLR) in Oral Potentially Malignant Dis-orders and Oral Cancer. Indian Journal of Pathology and Microbiology, 64, 243-249. [Google Scholar] [CrossRef] 
[9] Polk, N., Budai, B., Hitre, E., Patócs, A. and Mersich, T. (2022) High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival after Metastasectomy of Patients with Liver-Only Metastasis of Rectal Cancer. Pathology and Oncology Re-search, 28, Article ID: 1610315. [Google Scholar] [CrossRef] [PubMed]
[10] Gong, Z., Xin, R., Li, L., Lv, L. and Wu, X. (2022) Plate-let-to-Lymphocyte Ratio Associated with the Clinicopathological Features and Prognostic Value of Breast Cancer: A Meta-Analysis. The International Journal of Biological Markers, 37, 339-348. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, X., Chen, X., Yang, J., Li, Y., Fan, W. and Yang, Z. (2020) Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of Computer Assisted Tomography, 44, 275-283. [Google Scholar] [CrossRef] 
[12] Fisher, C.S., Ma, C.X., Gillanders, W.E., Aft, R.L., Eber-lein, T.J., Gao, F. and Margenthaler, J.A. (2012) Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response. Annals of Surgical Oncology, 19, 253-258. [Google Scholar] [CrossRef] [PubMed]
[13] Heng, D.Y., Xie, W., Regan, M.M., Warren, M.A., Golshayan, A.R., Sahi, C., Eigl, B.J., Ruether, J.D., Cheng, T., North, S., Venner, P., Knox, J.J., Chi, K.N., Kollmannsberger, C., McDermott, D.F., Oh, W.K., Atkins, M.B., Bukowski, R.M., Rini, B.I. and Choueiri, T.K. (2009) Prognostic Factors for Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Fac-tor-Targeted Agents: Results from a Large, Multicenter Study. Journal of Clinical Oncology, 27, 5794-5799. [Google Scholar] [CrossRef] 
[14] Ocana, A., Nieto-Jiménez, C., Pandiella, A. and Templeton, A.J. (2017) Neutrophils in Cancer: Prognostic Role and Therapeutic Strategies. Molecular Cancer, 16, Article No. 137. [Google Scholar] [CrossRef] [PubMed]
[15] Templeton, A.J., McNamara, M.G., Šeruga, B., Vera-Badillo, F.E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J.J., Tran, B., Tannock, I.F. and Amir, E. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
[16] Grassadonia, A., Graziano, V., Iezzi, L., Vici, P., Barba, M., Pizzuti, L., Cicero, G., Krasniqi, E., Mazzotta, M., Marinelli, D., Amodio, A., Natoli, C. and Tinari, N. (2021) Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Set-ting. Cells, 10, 1685. [Google Scholar] [CrossRef] 
[17] Chou, H.H., Kuo, W.L., Yu, C.C., Tsai, H.P., Shen, S.C., Chu, C.H., Yu, M.C., Lo, Y.F, Dabora, M.A., Chang, H.K., Lin, Y.C., Ueng, S.H. and Chen, S.C. (2019) Impact of Age on Pathological Complete Response and Locoregional Recurrence in Locally Advanced Breast Cancer after Neoad-juvant Chemotherapy. Biomedical Journal, 42, 66-74. [Google Scholar] [CrossRef] [PubMed]
[18] Keskin, S., Muslumanoglu, M., Saip, P., Karanlık, H., Guveli, M., Pehlivan, E., Aydoğan, F., Eralp, Y., Aydıner, Y., Yavuz, E., Ozmen, V., Igci, A. and Topuz, E. (2011) Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy. Oncology, 81, 30-38. [Google Scholar] [CrossRef] [PubMed]
[19] Chen, X., He, C., Han, D., Zhou, M., Wang, Q., Tian, J., Li, L., Xu, F., Zhou, E. and Yang, K. (2017) The Predictive Value of Ki-67 before Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis. Future Oncology, 13, 843-857. [Google Scholar] [CrossRef] [PubMed]
[20] Symmans, W.F., Peintinger, F., Hatzis, C., Rajan, R., Kuerer, H., Valero, V., Assad, L., Poniecka, A., Hennessy, B., Green, M., Buzdar, A.U., Singletary, S.E., Hortobagyi, G.N. and Pusztai, L. (2007) Measurement of Residual Breast Cancer Burden to Predict Survival after Neoadjuvant Chemotherapy. Journal of Clinical Oncology, 25, 4414-4422. [Google Scholar] [CrossRef] 
[21] Hagenaars, S.C., de Groot, S., Cohen, D., Dekker, T.J.A., Charehbili, A., Meershoek-Klein Kranenbarg, E., Duijm-de Carpentier, M., Pijl, H., Putter, H., Tollenaar, R., Kroep, J.R. and Mesker, W.E. (2021) Tumor-Stroma Ratio Is Associated with Miller-Payne Score and Pathological Response to Ne-oadjuvant Chemotherapy in HER2-Negative Early Breast Cancer. International Journal of Cancer, 149, 1181-1188. [Google Scholar] [CrossRef] [PubMed]

为你推荐